The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...

Latest News

Obesity Drug MariTide Achieves Up to 20% Weight Loss in Phase 2 Trial | Image Credit: Amgen
Obesity Drug MariTide Achieves Up to 20% Weight Loss in Phase 2 Trial

November 26th 2024

Amgen’s MariTide achieved up to 20% average weight loss at 52 weeks without hitting a plateau in individuals with obesity or overweight.

FDA Accepts Alnylam’s sNDA for Vutrisiran for ATTR-CM | Image Credit: US Food and Drug Administration
FDA Accepts Alnylam’s sNDA for Vutrisiran for ATTR-CM

November 26th 2024

US FDA logo in black over a white background. | Credit: US Food and Drug Administration
FDA Approves Acoramidis (Attruby) for ATTR-CM

November 23rd 2024

Stephen Nicholls, MBBS, PhD | Credit: Monash University
Muvalaplin, an Oral Lp(a)-Lowering Agent, Shows Promise in Phase 2 KRAKEN Trial

November 19th 2024

Steve Nissen, MD | Credit: Cleveland Clinic
Zerlasiran 60-Week Data Reinforce Lp(a) Reductions Observed in ALPACAR-360

November 18th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.